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Abstract 
Purpose:  Although self-expanding carotid stents may dilate gradually, the degrees of 
residual stenosis have been quantified by the NASCET criteria, which is too simple to 
reflect the configuration of the stented artery.  We measured the volumes of the stent 
lumens chronologically by 3D-CT in patients after carotid artery stenting (CAS), and 
analyzed the correlations between the volume change and medical factors. 
Methods:  Fourteen patients with carotid artery stenosis were treated using 
self-expanding, open-cell stents.  All patients underwent preoperative plaque MRI 
(magnetization-prepared rapid acquisition gradient-echo, MPRAGE) and chronological 
3D-CT examinations of their stents immediately after their placement and 1 day, 1 week, 
and 1 month after the procedure.  The volume of the stent lumen was measured using a 
3D workstation.  The correlations between stent volume and various factors including 
the presence of underlying diseases, plaque characteristics, and the results of the CAS 
procedure were analyzed. 
Results:  Stent volume gradually increased in each case and had increased by 
1.04-1.55 (mean, 1.25)-fold at 1 postoperative month.  The presence of underlying 
medical diseases, plaque length, the degree of residual stenosis immediately after CAS, 
and plaque calcification did not have an impact on the change in stent volume.  On the 
other hand, the stent volume increase was significantly larger in the patients with 
vulnerable plaques that demonstrated high MPRAGE signal intensity (P<0.05). 
Conclusions:  A 3D-CT examination is useful for precisely measuring stent volume.  
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Self-expanding stents in carotid arteries containing vulnerable plaques expand 
significantly more than those without such plaques in a follow-up period. 
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List of Abbreviations: CAS = carotid artery stenting; CI = confidence interval; HU = 
Hounsfield unit; ICC = intraclass correlation coefficients; MPRAGE = 
magnetization-prepared rapid acquisition gradient-echo; NASCET = the North 
American Symptomatic Carotid Endarterectomy Trial; WW/WL = window width and 
window level 
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Introduction 
CAS is performed as an alternative treatment for carotid artery stenosis in patients 
for whom endarterectomy is considered to be high-risk.  Today, self-expanding stents 
are widely used because of their flexibility and conformability.  Previous authors have 
reported that self-expanding stents gradually dilate, even after placement in biliary 
tracts [1], coronary [2, 3] or carotid arteries [4-8].  However, they evaluated stent 
dilatation using plain radiography, angiography, or ultrasound imaging and quantified 
the degree of stenosis using the NASCET criteria [9].  We agree that the NASCET 
method is quite useful because of its simplicity and good interobserver reproducibility, 
but it is a one-dimensional evaluation method and does not reflect the overall 
configuration of the stented artery.  In the recent studies examining the flow dynamics 
of carotid arteries [10, 11], it was difficult to elucidate the hemodynamic conditions 
within the arteries from the degree of stenosis determined using the NASCET method 
alone.  Carotid arteries and deployed stents are three-dimensional structures, and stents 
dilate not only at the most stenotic point but also in other regions after they have been 
deployed.  Additionally, if we can clarify the special conditions under which 
chronological expansion of self-expanding stents is observed more significantly, CAS 
procedures for the patients with such conditions may be tailored.  Postoperative 3D-CT 
images can clearly depict the deployed stent that demarcates the lesion of carotid 
stenosis.  In this study, we measured stent volumes based on 3D-CT images to more 
precisely evaluate the time course of stent dilatation and attempt to find factors that 
impact on the changes of stent volume. 
5 
 
Methods 
This study was approved by the institutional ethical committee of Okayama 
University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences. 
 
Patient population 
From January 2009 to December 2010, 34 CAS procedures were performed at our 
hospital on 31 consecutive patients with symptomatic or asymptomatic carotid artery 
stenosis of >60% degree on the NASCET criteria confirmed by digital subtraction 
angiography.  A Precise stent (Cordis endovascular, Miami Lakes, FL) was used in 27 
cases, and a Wallstent (Boston Scientific, Natick, MA) was used in 7 cases.  We 
excluded a small group of the patients treated using a Wallstent that has different 
natures of the device.  This study included the patients in whom the follow-up 
radiological 3D-CT imaging studies as mentioned below were completed.  Clinical 
data regarding the patients’ medical background were obtained from their medical 
records. 
Finally, 14 patients who were successfully treated with Precise stents and completely 
followed-up with 3D-CT imaging were included.  A Precise stent was appropriately 
deployed to the target lesion in each case, and there were no complications.  The 
patients’ background and plaque characteristics are summarized on Table 1.  Eleven 
patients had a history of transient ischemic attack or stroke within 90 days before CAS, 
and 3 patients were asymptomatic despite displaying carotid stenosis of >60% on 
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angiography.  Twelve patients were hypertensive, 7 had dyslipidemia, and 6 had diabetes 
mellitus. 
 
CAS procedure 
The administration of both aspirin (100 mg/day) and clopidogrel (75 mg/day) was 
initiated 7-10 days before the CAS procedure and was continued for at least 3 months 
after the procedure.  CAS was performed by two educators certified by Japanese 
Society for Neuroendovascular Therapy (K.T. and K.S.) using a distal protection device, 
such as an AngioGuard EX (Cordis endovascular), FilterWire EZ (Boston Scientific) or 
PercuSurge GuardWire (Medtronic, Santa Rosa, CA).  The lesion was pre-dilated with 
a 3.0 mm diameter angioplasty balloon, and an 8, 9, or 10 mm diameter, open-cell, 
self-expanding stent (Precise stent, Cordis endovascular) was deployed.  The size of 
the deployed stent was 1.0-1.5 mm larger than the estimated diameter of the common 
carotid artery.  All stents were post-dilated using 3.0-5.0 mm balloons, which were 
0.5-1.0 mm smaller than the diameter of the distal internal carotid artery. 
 
Postoperative chronological 3D-CT exams  
Postoperative 3D-CT images were obtained with a 16-channel multidetector row CT 
scanner (Aquilion 16, Toshiba, Tokyo, Japan) using the following settings: section 
thickness: 1.0 mm, table feed: 30 mm/s, gantry rotation time: 0.5 s, pitch factor: 0.94, 
tube voltage: 120 kV, tube current: 150 mA.  The 3D-CT examinations were 
performed immediately after the stent placement, and at 1 day, 1 week, and 1 month 
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after the procedure.  No contrast agent was used for the 3D-CT as it was only 
necessary to visualize the frame of the stent.  The examination performed at 1 week 
after the CAS included both plain 3D-CT and enhanced 3D-CT angiography using a 
contrast agent so as to allow the detection of in-stent thrombosis.  
 
Measurement of stent volume 
The volume of the stent was measured using a 3D workstation (ZIO station, Amin 
Co., Ltd., Tokyo, Japan) (Fig.1).  We constructed a 3D volume rendering image of the 
stent from the DICOM data, and the stent was segmented using the threshold technique.  
By setting WW/WL at appropriate levels for delineating the boundaries of the stent 
(WW/WL=500/1500 HU; values obtained from a phantom study), the stent was 
successfully separated from the surrounding tissue.  The stent border was outlined 
manually, and the non-stent area was removed.  Finally, the volume of the stent was 
automatically calculated by the workstation. 
 
CT of plaque calcification 
Plaque calcification was evaluated based on axial CT images preoperatively.  The 
cut-off point between calcified tissue and other tissues was set at 130 HU, as 
documented in previous studies [12].  A calcification arc involving more than 50% of 
the vessel circumference was defined as heavy calcification, that involving 25% to 50% 
of the vessel circumference was classified as moderate calcification, and that involving 
less than 25% of the vessel circumference was defined as light calcification. 
 
8 
  
MRI for assessing plaque vulnerability 
The preoperative MRI evaluation of plaque characteristics was performed with 3D 
inversion-recovery-based T1-weighted MR imaging (MPRAGE) using axial sections, a 
black-blood sequence (inversion time: 650 msec, TR: 1300msec), and fat suppression 
(water excitation technique) [13, 14].  We used standard neck array and spine array 
coils and a Magnetom Verio 3.0-T system (Siemens Medical Solution, Erlangen, 
Germany).  The scan covered the stenotic lesion and the carotid artery bifurcation, and 
the other scanning parameters were as follows: TE: 3.23 msec, FOV: 260 × 260 mm, 
matrix: 256 × 256, section thickness: 1.0 mm, flip angle: 10°, and data acquisition time: 
310 seconds.  
The MR images were reviewed by an experienced neurosurgeon (T.H.).  The signal 
intensity of the carotid plaque was assessed on MPRAGE MRI relative to that in the 
adjacent sternocleidomastoid muscle measured by placing a round region of interest 5-8 
mm in diameter in the area with homogenous signal intensity.  A plaque displaying 
signal intensity of greater than 200% relative to that of the muscle was categorized as a 
MPRAGE high intensity plaque (Fig. 2A, B).  
 
Inter-/intraobserver variability 
To determine the levels of intraobserver and interobserver variability, ICC with 95% 
CI were calculated.  Two observers independently reviewed the CT images and 
measured the volume of the stent lumen (first, H.I.; second, Y.O.).  Each observer was 
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blinded to the other's assessment.  The first observer repeated the volume measurement 
after a >6-month interval.  
  
Statistical analysis 
We analyzed the relationships between the rate of change in stent volume and various 
factors, including underlying medical conditions (hypertension, dyslipidemia, diabetes 
mellitus), residual rate of stenosis immediately after CAS, and plaque characteristics 
(calcification, lesion length, and signal intensity on MPRAGE MRI).  The 
Mann-Whitney U test was used to assess the changes in stent volume and the 
correlations between stent volume and various factors.  Residual stenosis after stent 
placement and lesion length were treated as continuous variables and assessed through 
nonparametric analysis using Spearman’s rank correlation coefficient.  Statistical 
analysis was performed with JMP ver. 9.0.0 (SAS Institute Inc., Cary, NC).  
Differences were considered significant at P values of <0.05. 
 
Results 
3D-CT data were obtained immediately after the CAS procedure, and follow-up CT 
examinations were performed at 1 day, 1 week (mean ± SD; 5.9 ± 0.9 days), and 1 
month after the procedure (34.5 ± 8.3 days) (Fig. 2C).  The ICC for the intraobserver 
and interobserver variability in the stent volume measurements were 0.92 and 0.86, 
respectively, both of which indicated excellent correlations.  The devices used and the 
stent volume measurements are shown in Table 2.  The mean ratios of the volume 
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recorded at each time point to that observed immediately after the CAS were 1.06 at 1 
day, 1.13 at 1 week, and 1.25 at 1 month (Fig. 3).  There were statistically significant 
increases between each time point (day 0 to day 1: P=0.0018, day 1 to 1 week: 
P=0.0077, 1 week to 1 month: P=0.0063, and P<0.0001: day 0 to 1 month; 
Mann-Whitney U test; Fig 3).  Case 14 displayed the smallest change in stent volume 
at 1 month after the procedure (1.04 fold increase), whereas Case 3 demonstrated the 
largest increase (1.55 fold). 
The relationships between the rate of change in stent volume and various factors are 
demonstrated in Fig. 4.  There were no significant relationships between the volume 
changes observed at 1 month after the procedure and any of the medical conditions 
(hypertension: P=0.784, dyslipidemia: P=0.798, diabetes mellitus: P=1.000; 
Mann-Whitney U test).  Neither the postoperative residual rate of stenosis or lesion 
length had a significant impact on the degree of stent expansion (residual stenotic rate: 
Spearman ρ=0.0515, P=0.861; lesion length: ρ=0.195, P=0.377).  Although the 
patients with smaller stent volume immediately after CAS demonstrated the larger rate 
of the volume change in one month (Spearman ρ=-0.552, P=0.046), their absolute 
values of the stent volume one month later were still smaller (Spearman ρ=0.858, 
P=0.002).  There were no significant differences in the volume change ratios among 
the 8 mm, 9 mm, and 10 mm diameter stents, nor did the presence or absence of 
calcification involving >50% or >25% of the vessel circumference have a significant 
effect on stent volume (P=1.000, 0.894, respectively).  On the other hand, in the 
patients with plaques displaying high signal intensity on MPRAGE, the rate of volume 
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change in the month after the procedure was significantly greater than that in the 
patients with low intensity plaques (P=0.0332). 
 
Discussion 
Chronological measurement of stent volume 
The degree of carotid artery stenosis is usually expressed by NASCET method or as 
the cross-sectional area of the region displaying the greatest stenosis.  However, these 
indices do not reflect the overall configuration of the stent.  We adopted the stent 
lumen volume as an index for evaluating ongoing stent dilatation.  This is the first 
paper to report the chronological changes in carotid stent volume based on 3D-CT 
images.   For aortic aneurysms, difficulty in assessing the three-dimensional structures 
with one-dimensional measurement systems and superiority of volumetric measurement 
were reported [15, 16].  Yao et al [17] measured the segmental vessel volume of the 
carotid artery before and after carotid endarterectomy in a 3D ultrasound study.  We 
used 3D-CT data to measure stent volume because 3D-CT allows clearer visualization 
of the artery and the stent than other techniques such as MR angiography and duplex 
sonography.  3D-CT also has a good resolution, making it easy to eliminate the 
structures surrounding the stent. 
Various authors have reported that self-expanding stents enlarge over time after 
deployment [1, 4-7], and previous coronary IVUS studies found that self-expanding 
stents continued to enlarge over the 6 month study period [18].  Bussière et al [6] 
detected the enlargement of self-expanding carotid stents and concluded that additional 
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balloon angioplasty might not be required.  Clark et al [5] reported that the 
cross-sectional areas of the carotid stents in their population had increased by 48.9% at 
the 6 months follow-up.  Our results demonstrated a 25% increase in the mean stent 
volume at the 1 month follow-up examination.  The volume of the stent lumen might 
increase more over a longer follow-up period, although it is not easy to directly compare 
our results with those of previous reports because of the different measuring methods 
employed. 
 
MPRAGE MRI and stent dilatation 
In our study, the stents deployed in carotid arteries containing atherosclerotic plaques 
that displayed high signal intensity on MPRAGE MRI were dilated more than those in 
arteries containing low intensity plaques.  This suggests that plaque characteristics 
impact on the time course of stent dilatation.  Willfort-Ehringer et al [7] reported that 
the expansion of the central diameter of carotid stents was most pronounced in areas 
containing echo-lucent “soft” plaques.  MPRAGE MRI has been reported to be useful 
for evaluating plaque characteristics [14, 19].
 
  Hishikawa et al [13] found that plaques 
that displayed high signal intensity on MPRAGE consisted of a large necrotic core and 
intraplaque hemorrhaging.  The plaques that displayed low signal intensity on 
MPRAGE were found to contain fibrous components, and hence, were more rigid.   
The necrotic core inside lipid-rich soft plaques can protrude through the stent struts 
during CAS procedures [20].  This deformation leads to in-stent thrombus and embolic 
complications [21].  Given the expectation of delayed expansion, it may be reasonable 
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to avoid an immediate large increase in the lumen in order to prevent plaque protrusion 
in patients with vulnerable plaques.  The Precise stent has a strong radial force, which 
contributes to its delayed expansion, but plaque protrusion might occur more easily.  
Fortunately, we did not encounter the cases with early plaque protrusion or in-stent 
thrombosis in our series.  In the future, it will be necessary to design stents in 
consideration of both the prevention of plaque protrusion and the desired degree of 
postoperative stent dilatation.  
 
Impacts of underlying medical factors and calcification on stent dilatation 
Bussière et al demonstrated that the absence of dyslipidemia was predictive of an 
increased risk of unsuccessful treatment with stenting alone; i.e., without angioplasty 
[6].  In our study, most of the patients with a history of dyslipidemia had already 
received cholesterol-lowering drugs, so no significant correlation between a history of 
dyslipidemia and chronological stent dilatation was detected.  
Severe calcification in coronary and carotid lesions is also considered to be a 
predictor of incomplete expansion [22-24].  In our study, plaque calcification did not 
have a significant influence on the time course of stent dilatation.  Even “heavy 
calcification"; i.e., that involving more than 50% of the vessel circumference, had no 
significant impact.  Tsutsumi et al [25] revealed fragmentation of a calcified lesion 
after CAS in patients with highly calcified plaques, and similar findings were observed 
in some of our cases.  Post-dilatation was performed in all of our cases, so the calcified 
lesions might have been fragmented, and hence, only had a small effect on stent 
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dilatation.  However, as patients with extremely thick calcifications are not eligible for 
CAS at our institution, the effects of calcification might have been underestimated. 
 
Study limitations 
First, this was a retrospective study with a small sample size and a short observation 
period.  In future studies consisting of a larger number of patients and a longer 
follow-up period, we might be able to clarify an acceptable degree of residual stenosis 
after CAS based on patient-specific radiological and medical conditions.  Second, we 
only measured the volume of the stent lumen and ignored possible neointimal 
hyperplasia or thrombosis inside the stent because it was difficult to set appropriate 
WW/WL thresholds for delineating the boundaries of the vessel lumen.  Accordingly, 
changes in stent volume do not directly reflect the actual change in the size of the vessel 
lumen, although Watarai et al detected chronological increases in the size of the vessel 
lumen that were proportional to the dilatation of the stent diameter until 12 weeks after 
CAS [8].  In future studies, the vessel lumen should be measured in order to evaluate 
the relationship between the changes in stent lumen and those of the vessel lumen.  
Third, the measurement of stent volume was mostly performed using a time-consuming 
manual process in this study.  It took around one hour to measure the volume of one 
stent.  The development of new software for automatically measuring the volume of 
the stent lumen would contribute toward advancing this kind of study. 
 
Conclusions 
15 
A 3D-CT examination is useful for precisely measuring stent volume and evaluating 
the time course of its expansion.  Self-expanding stents in carotid arteries containing 
vulnerable plaques expand significantly more than those without such plaques in a 
follow-up period.  For patients with vulnerable plaques in whom delayed large 
expansion of the stent can be expected, it may be reasonable to avoid an immediate 
large increase in the lumen during CAS in order to prevent production of a large amount 
of debris or plaque protrusion.   
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Figure legends 
Fig 1. Measurement of stent volume based on 3D-CT images 
 A: A volume-rendering image of a carotid stent and the srrounding bones.  B: An MIP 
image obtained before adjusting the window width and window level (WW/WL).  C: 
The border of the stent could be clearly visualized from the same angle by using 
appropriate WW/WL settings (500/1500).  D: The border of the stent was manually 
outlined, and the non-stent area was removed.  The volume of the stent was 
automatically calculated. 
 
Fig. 2. Time course of the increase in stent volume in Case 3, which involved a 
vulnerable plaque. 
A: A left common carotid arteriogram showing severe stenosis in the left internal carotid 
artery.  B: MPRAGE MRI demonstrating a carotid plaque (arrow) displaying a signal 
intensity that was 2.58 fold higher than that of the adjacent muscle (arrowhead).  C: 
MIP images showing a stent with a volume of 1.19 cm
3
 immediately after stent 
placement (left), 1.26 cm
3
 1 week later (center), and 1.85 cm
3
 1 month later (right). 
 
Fig 3. Graphs demonstrating the time course of the change in the mean ratio of the 
stent volume at each time point to that observed immediately after CAS. 
 The dashed line represents the mean values for each period, which significantly 
increased between each period.  
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Fig 4. Graphs showing the rate of volume change at 1 month after CAS in the 
patients with or without various medical factors and radiological findings. 
 The stents deployed in carotid arteries with plaques that displayed high intensity on 
MPRAGE MRI expanded more significantly than those deployed in arteries that 
demonstrated low intensity on MPRAGE MRI at the 1-month follow-up (P=0.0332).  
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Fig. 1 
 
Fig. 2 
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Fig. 3 
 
Fig. 4 
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Table 1: Patient summary – background and plaque characteristics 
 
 
 
 
 
 
 
 
No. 
Age(y)/ 
Sex lesion HT HL DM calcification MPRAGE 
lesion 
length(mm) 
stenosis(%) 
pre post 
1 71M Lt Sx + - - light high 21  90  20  
2 77M Rt Sx - + + - low 8  80  0  
3 71M Lt Sx + + - - high 18  85  20  
4 67M Rt Sx + - + - high 16  95  25  
5 77M Rt Sx - - - heavy low 17  80  10  
6 66M Rt ASx + + - heavy high 25  60  30  
7 77M Rt ASx + - - light high 17  60  20  
8 72M Lt Sx + - + light high 21  95  25  
9 74M Rt Sx + + + heavy high 15  95  20  
10 80M Rt Sx + + - light low 15  70  30  
11 81M Rt Sx + + + light low 11  90  0  
12 76M Rt Sx + - + light low 30  90  5  
13 78M Lt Sx + - - moderate high 29 80  40  
14 75M Lt ASx + + - heavy low 8 85  40  
Rt/Lt: right/left, Sx: symptomatic, Asx: asymptomatic, M: man, HT: hypertension,  
HL: hyperlipidemia, DM: diabetes mellitus,  
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Table 2: Patient summary – devices and stent volume 
 
No. 
devices volume of the stent lumen (cm3) 
stent EPD pre dilatation post dilatation day 0 day 1 1 week 1 month 
1 Precise 9/40 GW Sterling 3.0/40 Sterling 4.0/30 1.45 1.55 1.67 2.00 
2 Precise 10/40 AG N/A Submarine 4.0/20 2.39 2.39 2.89 3.00 
3 Precise 8/40 AG Sterling 3.0/40 Submarine 4.0/40 1.19 1.26 1.26 1.85 
4 Precise 10/40 GW Submarine 3.0/40 Aviator 4.0/30 1.78 2.00 2.20 2.57 
5 Precise 10/40 AG Submarine 3.0/40 Sterling 5.0/30 2.19 2.36 2.50 2.73 
6 Precise 8/40 AG Sterling 3.0/40 Aviator 4.0/30 1.40 1.50 1.70 1.88 
7 Precise9 /40 AG Submarine 3.0/40 Sterling 4.0/30 2.03 2.10 2.30 2.36 
8 Precise 8/40 AG Sterling 3.0/40 Aviator 4.0/30 1.92 1.99 2.11 2.28 
9 Precise 8/40  GW Submarine 3.0/40 Sterling 4.0/40 1.43 1.61 1.65 1.87 
10 Precise 10/40  GW Submarine 3.0/40 Sterling 4.5/20 2.38 2.38 2.54 2.70 
11 Precise 8/40 GW Sterling 3.0/40 Sterling 3.0/40 1.88 1.97 2.02 2.13 
12 Precise 10/40 GW Sterling 3.0/40 Sterling 4.5/30 2.11 2.28 2.34 2.44 
13 Precise 8/40 GW Stering 3.0/40 Aviator 4.0/30 2.03 2.29 2.24 2.40 
14 Precise 8/40 FW Stering 3.0/40 Jackal 4.0/30 1.79 1.75 1.85 1.86 
EPD: embolic protection device, GW: PercuSurge GuardWire,  
AG: Angioguard EX, FW: FilterWire EZ, N/A: not applied 
 
 
